Search hospitals > Ohio > Toledo
St. Vincent Mercy Medical Center
Claim this profileToledo, Ohio 43608
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast cancer
334 reported clinical trials
4 medical researchers
Summary
St. Vincent Mercy Medical Center is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Pancreatic Cancer, Breast cancer and other specialties. St. Vincent Mercy Medical Center is involved with conducting 334 clinical trials across 482 conditions. There are 4 research doctors associated with this hospital, such as Timothy D. Moore, Osama Zaidat, MD, Ameer Kabour, and Adnan R Alkhalili.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage IV
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
126 reported clinical trials
208 drugs studied
Osama Zaidat, MDMercy Health St. Vincent Medical Center3 years of reported clinical research
Studies Stroke
Studies Intracranial Aneurysm
12 reported clinical trials
22 drugs studied
Ameer KabourMercy Health St. Vincent Medical Center LLC4 years of reported clinical research
Studies Coronary Artery Disease
Studies Heart Failure
4 reported clinical trials
5 drugs studied
Adnan R AlkhaliliMercy Health - St. Vincent Medical Center3 years of reported clinical research
Studies Breast Cancer
Studies Pancreatic Cancer
2 reported clinical trials
7 drugs studied
Clinical Trials running at St. Vincent Mercy Medical Center
Lung Cancer
Bladder Cancer
Melanoma
Cutaneous Melanoma
Bladder Carcinoma
Esophageal cancer
Multiple Myeloma
Cancer
Breast Cancer
Uterine Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at St. Vincent Mercy Medical Center?
St. Vincent Mercy Medical Center is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Pancreatic Cancer, Breast cancer and other specialties. St. Vincent Mercy Medical Center is involved with conducting 334 clinical trials across 482 conditions. There are 4 research doctors associated with this hospital, such as Timothy D. Moore, Osama Zaidat, MD, Ameer Kabour, and Adnan R Alkhalili.
Where is St. Vincent Mercy Medical Center located?
St. Vincent Mercy Medical Center is located at 2213 Cherry St., near the intersection of Cherry St. and Collingwood Blvd., Toledo, OH. For real-time driving directions, consider using GPS navigation services to reach the hospital's emergency department at this address.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at St. Vincent Mercy Medical Center, contact the centralized billing and insurance department at 800-494-5797, available from 9 a.m. to 5 p.m. For more information on financial assistance options, visit their website. Specific questions about the hospital's financial assistance policy can be directed to the financial counselors at 216-694-4652 or 216-694-4653.
What insurance does St. Vincent Mercy Medical Center accept?
St. Vincent Mercy Medical Center accepts a wide range of insurance plans, including but not limited to Aetna, Anthem Blue Cross Blue Shield, Beech Street, Cigna, Coventry, Humana, and UnitedHealthcare. It's important to verify with your insurance provider as participation can vary by product and may change. Ensure to confirm coverage for specific services like lab work or imaging, as using out-of-network facilities may result in denial of coverage and full charges.
What awards or recognition has St. Vincent Mercy Medical Center received?
St. Vincent Mercy Medical Center, located in Toledo, Ohio, is renowned for its Heart Center, Pediatric Diabetes Program, and Comprehensive Cancer Centers. The hospital boasts an accredited pediatric residency program. It has also earned the Joint Commission’s Advanced Certification for Comprehensive Stroke Center, representing the highest level of accreditation in stroke care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.